Back

Chimeric protein EWS-FLI1 drives cell proliferation in Ewing Sarcoma via overexpression of KCNN1.

Dupuy, M.; Gueguinou, M.; Postec, A.; Brion, R.; Tesfaye, R.; Mullard, M.; Regnier, L.; Amiaud, J.; Potier-Cartereau, M.; Chantome, A.; Brounais-Le Royer, B.; Baud'huin, M.; Georges, S.; Lamoureux, F.; Ory, B.; Delattre, O.; Redini, F.; Vandier, C.; Verrecchia, F.

2023-04-28 cancer biology
10.1101/2023.04.24.538050 bioRxiv
Show abstract

Ewing sarcoma (ES) is characterized by chimeric fusion proteins, which act as oncogenes. Over the last decade, patient survival has not increased, especially for high risk patients. Knowing that ion channels are studied for their implication in tumorigenesis, the aim of this work is to study the involvement of the SK1 potassium channels in ES. RNA-Seq analyses showed a high restricted expression of KCNN1, the gene encoding SK1, only in ES patients, and its expression is inversely correlated with patient survival. EWS-FLI1 silencing demonstrated the regulation of KCNN1 by these fusion proteins, which bind at GGAA microsatellites near KCNN1 promoter. In addition, KCNN1 has been shown to be involved in the regulation of ES cell proliferation, its silencing being associated with a slowing of the cell cycle. Finally, KCNN1 expression modulates membrane potential and calcium flux suggesting the role of calcium in KCNN1 driving cell proliferation. These results highlight that KCNN1 is a direct EWS-FLI1 and EWS-ERG target, and is involved in the regulation of ES cell proliferation, making it an interesting therapeutic target in ES.

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

1
Journal of Experimental & Clinical Cancer Research
○ 25 papers in training set
Top 0.1%
6.7%
Similar papers in this journal
2
Biomedicines
○ 67 papers in training set
Top 0.1%
5.5%
Similar papers in this journal
3
Scientific Reports
○ 3612 papers in training set
Top 16%
5.5%
Similar papers in this journal
4
Stem Cell Reports
○ 130 papers in training set
Top 0.6%
4.0%
Similar papers in this journal
5
Cellular and Molecular Life Sciences
○ 96 papers in training set
Top 0.2%
3.5%
Similar papers in this journal
6
Life Science Alliance
● 285 papers in training set
Top 1%
3.4%
7
Cell Death & Disease
147 papers in training set
Top 0.9%
3.2%
8
EMBO Reports
○ 263 papers in training set
Top 1%
3.2%
9
Cells
○ 249 papers in training set
Top 1%
3.2%
10
Molecular Oncology
○ 55 papers in training set
Top 0.3%
3.2%
11
Disease Models & Mechanisms
139 papers in training set
Top 0.7%
2.8%
12
EMBO Molecular Medicine
○ 95 papers in training set
Top 0.3%
2.8%
13
Cancers
○ 213 papers in training set
Top 2%
2.8%
14
Experimental Cell Research
○ 28 papers in training set
Top 0.2%
2.4%
50% of probability mass above
15
eLife
● 5828 papers in training set
Top 43%
2.4%
16
iScience
○ 1154 papers in training set
Top 12%
2.4%
17
Communications Biology
○ 993 papers in training set
Top 11%
2.1%
18
Oncogenesis
○ 12 papers in training set
Top 0.1%
1.7%
19
Open Biology
● 106 papers in training set
Top 0.6%
1.7%
20
International Journal of Molecular Sciences
○ 494 papers in training set
Top 9%
1.5%
21
Biology Open
● 156 papers in training set
Top 2%
1.4%
22
Oncogene
○ 85 papers in training set
Top 1%
1.1%
23
Frontiers in Cell and Developmental Biology
○ 233 papers in training set
Top 4%
1.1%
24
Cell Death & Differentiation
○ 48 papers in training set
Top 0.8%
1.1%
25
Cell Death Discovery
○ 58 papers in training set
Top 0.9%
1.1%
26
Biosensors and Bioelectronics
○ 57 papers in training set
Top 0.6%
1.1%
27
PLOS ONE
● 5266 papers in training set
Top 55%
1.0%
28
Genes
○ 144 papers in training set
Top 3%
1.0%
29
Journal of Cellular Biochemistry
○ 11 papers in training set
Top 0.3%
0.6%
30
Neoplasia
○ 23 papers in training set
Top 1%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.